Investigation Date: Mar 13, 2026
Insiders and early investors acquired shares at $0.01-0.05 CAD while current OTC price is $5.40 USD, representing a 10,000%+ cost basis advantage. What This Means: Nearly all upside from retail investment flows to insiders sitting on massive unrealized gains.
Founder/Insider Cost Basis:
Warrant Overhang:
Recent Private Placements:
Lock-up
Executive Compensation:
The cost basis disparity means retail investors purchasing on OTC markets are effectively funding massive windfall profits for insiders and early-stage participants who acquired shares at 1% of current levels.
Company claims leadership in graphene production and revolutionary applications, but evidence shows minimal revenue generation, reliance on government grants, and limited commercial traction despite years of operations. What This Means: The technology narrative appears disconnected from measurable business results.
"Leading producer of high-quality graphene with proprietary detonation synthesis process"
SEDAR+ filings show the company holds patents for graphene production methods, but revenue remains minimal. Q3 2024 revenue was $47,000 CAD primarily from government grants and R&D services, not commercial graphene sales.
Exaggerated — Technology exists but commercial leadership is not supported by revenue data
"Revolutionary applications in batteries, supercapacitors, and thermal management"
Company press releases cite partnerships with automotive and electronics companies, but Material Change Reports on SEDAR+ show these are primarily research agreements and pilot programs, not revenue-generating contracts.
Unverified — Partnerships exist but commercial application remains in development phase
"Scalable production capacity to meet growing market demand"
Financial statements show production facility costs but minimal inventory turnover. Operating expenses exceeded $1.2M CAD quarterly while revenue remained under $50K CAD, indicating production is not meeting commercial demand.
Contradicted — Capacity exists but demand is not materializing at commercial scale
"Addressing multi-billion dollar graphene market opportunity"
Market size claims reference third-party reports projecting graphene market growth, but company's actual market share remains negligible after several years of operations.
Exaggerated — Total addressable market may be large, but company's serviceable addressable market is unclear
Patent Portfolio:
The company's technical capabilities appear real but the commercial narrative significantly overstates current business traction and revenue generation.
Company is currently subject to a cease trade order from BC Securities Commission for failure to file required financial statements, and auditors have expressed substantial doubt about ability to continue as a going concern. What This Means: Regulatory compliance failures pose immediate risk to trading and business continuity.
Cease Trade Order (Current):
Going Concern Qualification:
Auditor History:
Regulatory Filings
Corporate Structure:
Legal Proceedings:
Compliance History:
The cease trade order represents an immediate structural risk that could affect liquidity and institutional investment eligibility.
Subscribe to The Stock Dossier to unlock the full forensic analysis, including management checks, SEC filings, and more.
$9.99/month. Cancel anytime.
Want to run your own forensic investigation?
Get Started with The Stock Dossier